Spyre Therapeutics Balance Sheet (2015-2026) | SYRE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)			2.80M				4.14M
Receivables - Accured (Quarter)	0.30M	0.10M	0.10M				0.10M	0.10M	0.10M	0.40M	0.90M	1.30M	1.80M	1.70M	3.40M	3.40M	3.50M	3.60M	4.50M	4.60M
Assets
Current Assets
Cash & Equivalents (Quarter)	34.77M	24.66M	15.14M	14.64M	37.47M	38.99M	34.86M	35.24M	235.36M	90.59M	188.89M	227.55M	45.14M	71.58M	89.42M	46.80M	81.66M	63.18M	85.72M	95.45M
Receivables - Net (Quarter)													5.90M	5.90M	5.90M
Receivables - Other (Quarter)			0.81M				0.38M	0.33M	1.65M	0.16M
Receivables (Quarter)													5.90M	5.90M	5.90M
Prepaid Assets (Quarter)	5.79M	5.09M	4.95M	4.86M	7.62M	7.87M	6.17M	5.57M	2.88M	2.19M	2.25M	2.63M	9.74M	6.85M	5.39M	4.95M	12.25M	18.41M	21.25M	22.49M
Current Assets (Quarter)	134.37M	117.51M	98.89M	72.60M	96.65M	82.22M	62.26M	44.38M	239.89M	205.95M	341.53M	487.27M	435.74M	421.08M	608.47M	569.77M	538.83M	504.60M	777.78M	763.95M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	5.21M	4.92M	4.55M	4.23M	3.89M	3.56M	3.22M	3.42M
Long-Term Deferred Tax (Quarter)							0.57M
Other Non-Current Assets (Quarter)	1.85M	0.90M	1.84M	1.83M	1.80M	1.53M	1.55M	0.08M	1.32M	1.31M	0.32M	0.32M	0.32M		0.01M	0.01M
Non-Current Assets (Quarter)	12.61M	11.55M	11.04M	10.57M	10.06M	9.35M	8.89M	8.08M	3.64M	1.32M	0.33M	0.33M	0.33M	0.01M	0.01M	0.01M
Assets (Quarter)	146.98M	129.06M	109.93M	83.17M	106.71M	91.57M	71.14M	52.45M	243.53M	207.26M	341.86M	487.60M	436.07M	421.09M	608.48M	569.78M	538.83M	504.60M	777.78M	763.95M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.22M	1.86M	3.32M	2.98M	1.96M	4.18M	0.68M	2.06M	2.85M	19.82M	16.58M	15.53M	3.23M	5.17M	0.67M	2.55M	0.03M	7.46M	0.01M	5.69M
Payables (Quarter)	2.22M	1.86M	3.32M	2.98M	1.96M	4.18M	0.68M	2.06M	2.85M	19.82M	16.58M	15.53M	3.23M	5.17M	0.67M	2.55M	0.03M	7.46M	0.01M	5.69M
Accumulated Expenses (Quarter)	2.90M	13.36M	14.03M	10.79M	13.14M	12.41M	12.84M	9.66M	28.43M	15.86M	13.11M	21.59M	5.68M	13.15M	27.71M	21.63M	19.42M	23.83M	26.95M	29.16M
Other Accumulated Expenses (Quarter)	1.13M	0.96M	0.78M	0.73M	0.46M	0.36M	0.33M	0.28M	0.39M		0.49M		0.23M	0.53M	0.50M	0.37M	0.24M	0.17M	0.18M	0.17M
Short term Debt (Quarter)									164.38M	7.51M	1.39M	2.59M	2.64M	24.74M	25.08M	42.81M	59.90M	11.02M	22.82M	50.26M
Current Leases (Quarter)	0.41M	0.41M	0.44M	0.46M	0.48M	0.59M	0.62M	0.61M	4.33M
Current Deferred Revenue (Quarter)	5.50M	6.40M	2.36M	2.80M	0.30M	0.51M	2.70M	0.30M	0.93M
Total Current Liabilities (Quarter)	20.60M	20.43M	20.14M	16.30M	15.86M	17.68M	14.66M	12.64M	232.23M	44.87M	31.98M	42.82M	22.12M	57.54M	54.06M	70.68M	83.06M	46.27M	58.69M	85.16M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)	2.27M	1.61M	1.22M	0.74M	2.37M	2.17M	2.18M	2.34M	2.34M
Preferred Stock Liabilities (Quarter)									197.32M	387.11M	84.56M	253.41M
Operating Leases (Quarter)	4.88M	4.75M	4.61M	4.47M	4.32M	4.16M	4.00M	3.82M
Other Non-Current Liabilities (Quarter)	0.20M	0.19M	0.02M	0.01M					164.38M	20.69M	41.31M	39.11M	39.56M	36.16M	36.62M	16.49M		3.23M	26.68M	56.95M
Total Non-Current Liabilities (Quarter)	27.76M	26.79M	25.97M	21.50M	22.55M	24.01M	20.84M		89.19M	44.87M	31.98M	42.82M	22.12M	57.54M	54.06M	70.68M	83.06M	46.27M	35.87M	36.19M
Total Liabilities (Quarter)	27.96M	26.98M	25.98M	21.51M	22.55M	24.01M	20.84M	18.80M	253.57M	65.56M	73.29M	81.93M	61.68M	93.70M	90.68M	87.17M	83.06M	49.50M	62.55M	93.14M
Shareholder's Equity
Total Debt (Quarter)									164.38M	7.51M	1.39M	2.59M	2.64M	24.74M	25.08M	42.81M	59.90M	11.02M	22.82M	50.26M
Common Equity (Quarter)	119.02M	102.08M	83.94M	61.66M	84.16M	67.56M	50.30M	33.65M	-207.37M	-245.40M	184.02M	152.27M	374.38M	327.39M	517.80M	482.61M	455.77M	455.10M	715.24M	670.81M
Shareholder's Equity (Quarter)	119.02M	102.08M	83.94M	61.66M	84.16M	67.56M	50.30M	33.65M	-207.37M	-245.40M	184.02M	152.27M	374.38M	327.39M	517.80M	482.61M	455.77M	455.10M	715.24M	670.81M
Liabilities and Shareholders Equity (Quarter)	146.98M	129.06M	109.93M	83.17M	106.71M	91.57M	71.14M	52.45M	243.53M	207.26M	341.86M	487.60M	436.07M	421.09M	608.48M	569.78M	538.83M	504.60M	777.78M	763.95M
Retained Earnings (Quarter)	-301.06M	-321.36M	-0.02M	-0.15M	-388.60M	-0.18M	-425.62M	-0.01M	0.01M	-701.23M	0.30M	-808.30M	-0.55M	1.46M	-972.43M	-1017.21M	-1053.92M	-1065.11M	0.87M	-1196.64M
Preferred Shares (Quarter)													9.39M	146.43M		9.39M		9.39M	146.43M
Treasury Shares (Quarter)			0.19M	0.19M	0.18M	0.15M	0.01M				0.15M				0.12M				0.08M
Shares Outstanding (Quarter)	49.03M	49.31M	1.97M	1.98M	2.45M	2.46M	2.61M	2.62M	3.24M	4.05M	36.06M	36.63M	50.78M	51.40M	60.26M	60.28M	60.37M	60.47M	78.19M	78.84M

Research Tools

Spyre Therapeutics Balance Sheet (2015-2026) | SYRE

Create an account

Sign In

Reset Password